Investor Presentation • Feb 26, 2025
Investor Presentation
Open in ViewerOpens in native device viewer

26 FEBRUARY 2025


All amounts in NOK 1,000
| Statement of comprehensive income |
Q4 2024 | Q4 2023 | 2024 | 2023 |
|---|---|---|---|---|
| 1.10 – 31.12 Unaudited |
1.10 – 31.12 Unaudited |
1.1 – 31.12 Unaudited |
1.1 – 31.12 |
|
| Operating income and expenses |
||||
| Revenue from contracts with customers | 8 | 1 | 190 | 37 279 |
| Other operating income |
134 | - | 134 | - |
| Total operating income |
142 | 1 | 324 | 37 279 |
| Change in biological assets at cost and other inventories |
- | - | - | -1 162 |
| Cost of materials | -101 | -429 | -375 | -59 638 |
| Fair value adjustments of biological assets | - | - | - | 25 707 |
| Employee benefit expenses | -5 377 | -5 424 | -21 683 | -25 208 |
| Depreciation and amortisation expenses |
-6 217 | -6 305 | -24 756 | -24 904 |
| Other operating expenses |
-7 679 | -7 283 | -25 450 | -31 707 |
| Total operating expenses |
-19 375 | -19 441 | -72 264 | -116 902 |
| Operating profit/loss | -19 232 | -19 440 | -71 940 | -79 634 |
| Financial income and expenses |
||||
| Financial income |
1 371 | 5 229 | 4 914 | 12 187 |
| Net financial costs | -215 | -137 | -837 | -2 340 |
| Net financial result |
1 156 | 5 092 | 4 077 | 9 847 |
| Profit/loss for the period |
-18 076 | -14 348 | -67 862 | -69 787 |


All amounts in NOK 1,000
| Assets | 31.12.2024 - Unaudited |
31.12.2023 |
|---|---|---|
| Intangible assets |
16 420 | 14 389 |
| Property, plant & equipment |
2 230 854 | 876 632 |
| Right-of-use assets |
13 060 | 17 640 |
| Other non-current assets |
139 | 113 |
| Total non-current assets |
2 260 473 | 908 774 |
| Biological assets |
- | - |
| Other inventories |
1 340 | 1 697 |
| Trade and other receivables | 44 | - |
| Other current assets |
76 443 | 52 361 |
| Cash and cash equivalents |
59 196 | 250 032 |
| Total current assets |
137 023 | 304 090 |
| Total assets |
2 397 496 | 1 212 864 |
Figures do not include an undrawn construction loan of NOK 40 million and an undrawn credit facility of NOK 20 million


All amounts in NOK 1,000
| Equity and liabilities | 31.12.2024 - Unaudited |
31.12.2023 |
|---|---|---|
| Total equity | 1 254 355 | 993 688 |
| Borrowings | 832 309 | 59 959 |
| Lease liabilities | 6 163 | 9 340 |
| Total non-current liabilities |
838 472 | 69 299 |
| Borrowings | - | 7 666 |
| Lease liabilities | 4 276 | 4 511 |
| Trade payables | 295 506 | 131 134 |
| Other current liabilities |
4 887 | 6 567 |
| Total current liabilities |
304 669 | 149 877 |
| Total liabilities | 1 143 141 | 219 176 |
| Total equity and liabilities |
2 397 496 | 1 212 864 |


Statement of cash flows Q4 2024 Q4 2023 2024 2023 1.10-31.12 Unaudited 1.10-31.12 Unaudited 1.1 – 31.12 Unaudited 1.1 – 31.12 Net cash flow from operating activities -22 089 -17 247 -63 227 -29 148 Net cash flow from investing activities -300 057 -256 776 -1 205 173 -326 866 Net cash flow from financing activities 219 165 -2 164 1 077 564 523 136 Net change in cash and cash equivalents -102 982 -276 186 -190 836 167 121 All amounts in NOK 1,000


Q1 2025 presentation – 28 May 2025
For more information on this presentation and its contents, please contact:
Bjarne Martinsen, CFO Andfjord Salmon [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.